- Company
- Daewoong,enters phase III of indications for Enavogliflozin
- by Nov 10, 2020 06:05am
- Daewoong (CEO Seung-ho Jeon) announced on the 30th of last month that it had received approval for a phase III clinical trial from the MFDS for the combination therapy of Enavogliflozin, Metformin, and DPP-4 inhibitor, which are being developed as a new drug for diabetes treatment. Enavogliflozin is a new drug for the treatment of SGLT-2 d
- Policy
- Kang-rip Kim emphasized COVID-19 tx & vaccine development
- by Lee, Tak-Sun Nov 10, 2020 06:05am
- Kang-rip Kim (54 yrs old), the new head of the MFDS, emphasized, "We must concentrate our regulatory competencies as much as possible for the development of COVID-19 treatment and vaccine." At the inauguration ceremony held at the headquarters of the MFDS in Osong, Chungbuk on the evening of the 2nd, he said that he is at the forefront o
- Company
- Covered drugs decreased due to generic drug price system
- by Chon, Seung-Hyun Nov 9, 2020 06:18am
- The soaring number of medicines covered by health insurance showed a sharp decline. As the number of new generic licenses decreased due to the implementation of the new drug price system, the number of covered drugs decreased in 11 months. According to the HIRA on the 8th, as of November 1, the total number of drugs on the health insuranc
- Company
- Generics for Lyrica, expanded by 60% in 3 years
- by Kim, Jin-Gu Nov 9, 2020 06:18am
- The market for Pregabalin, a pain treatment drug for peripheral neuropathy, has expanded rapidly over the past three years. The amount of outpatient prescriptions from &8361;19.8 billion in the third quarter of 2017 increased 61% to &8361;32 billion in three years. It is an analysis that the growth of generics after the expiration of th
- Policy
- MOHW “COVID-19 vaccine-treatment approval early next year”
- by Lee, Jeong-Hwan Nov 9, 2020 06:18am
- Minister Park Neung-hoo of Health and Welfare stated the South Korean government is anticipating a temporary use approval of COVID-19 vaccine in March next year and treatment early year. However, the minister said the vaccine would most likely to be an imported product by a multinational pharmaceutical company, and Korean-made treatment
- Company
- Rx performance is poor due to spin-off of Organon
- by Kim, Jin-Gu Nov 9, 2020 06:17am
- MSD Korea's spin-off of Organon has come for three months. However, sales of most Organon items, such as Singulair, Vitorin, and Cozaar, are sluggish in the domestic outpatient prescription market. In contrast, Sales of Januvia by MSD increased by nearly 10%. According to UBIST on the 4th, MSD's outpatient prescriptions in the third quarte
- Policy
- Antiviral Zovirax license transferred from GSK to Ilsung
- by Lee, Tak-Sun Nov 6, 2020 06:26am
- Used for decades in South Korea as an antiviral drug against herpes simplex virus (HSV) and varicella zoster virus (VZV), Zovirax (acyclovir) has completed the local sales rights transfer from GlaxoSmithKline (GSK) to Ilsung Pharmaceuticals An acyclovir original, Zovirax, lost ‘GSK’ from its name as recently GSK voluntarily dropped the
- Company
- Servier Korea has appointed Melanie Loresry as new CEO
- by Eo, Yun-Ho Nov 6, 2020 06:25am
- Servier Korea appoints a new head. According to related industries, Servier Korea appointed Melanie Loresry (43) as new CEO, on the 1st of last month. Colette Rouches, who had previously led Servier Korea, moved to a Taiwanese subsidiary. This allowed Servier to continue the female CEO system. French CEO Melanie Loresry has been in the
- Company
- MSD Korea’s trade union protests against organon's spinoff
- by Nov 6, 2020 06:25am
- The MSD Korea’s trade union began disputes on the 3rd due to the breakdown of the second round of mediation by the National Labor Relations Commission on the 2nd. On the 3rd, the union hung a picket and banner on the MSD Korea office building in Seoul Square, urging against the spin-off of Organon and urged cooperation in signing a colle
- Company
- Menarini Korea labor union in pursuit of stable job security
- by An, Kyung-Jin Nov 6, 2020 06:25am
- On Nov. 4, Korea Democratic Pharmaceutical Union reported Menarini Korea has recently established a labor union and joined the Democratic Union as a new chapter. Sources confirm the company union has completed the union registration on Oct. 28 and started their official activities from then on. Menarini Korea is a multinational company t
